Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03696225 · ClinicalTrials.gov registry record · NA

Assessment and Treatment of Cognitive Functioning Deficits in Veterans With PTSD

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT03696225: Completed NA study, sponsored by VA Office of Research and Development.

NCT03696225 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03696225, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

Approximately half a million Veterans receiving services at the VA have Posttraumatic Stress Disorder (PTSD). PTSD is strongly associated with cognitive functioning deficits in areas of concentration, attention, memory, learning, verbal abilities, processing speed, and multitasking. Compensatory Cognitive Training (CCT) is an evidence-based intervention for cognitive problems that is effective in other Veteran populations such as those with a history of traumatic brain injury (TBI), but CCT has not yet been tested in Veterans with PTSD who don't have a history of TBI. The investigators will conduct a pilot randomized controlled trial (RCT) of CCT in Veterans who have been treated for PTSD but continue to have cognitive functioning deficits. The investigators will examine feasibility, acceptability, participant characteristics, and effect size estimates in preparation for a fully-powered RCT of CCT for PTSD-related cognitive functioning deficits.

Interventions

  • BEHAVIORAL Treatment as Usual (TAU)
  • BEHAVIORAL Compensatory Cognitive Training (CCT)

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2019-03-06
Est. Completion 2025-12-29
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT03696225

The ClinicalTrials.gov registry entry for NCT03696225 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.

NCT03696225 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03696225 about?

NCT03696225 is a clinical study titled "Assessment and Treatment of Cognitive Functioning Deficits in Veterans With PTSD". Approximately half a million Veterans receiving services at the VA have Posttraumatic Stress Disorder (PTSD). PTSD is strongly associated with cognitive functioning deficits in areas of concentration, attention, memory, learning, verbal abilities, processing speed, and multitasking. Compensatory Cog...

What is the current status of trial NCT03696225?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2019-03-06. Estimated completion is 2025-12-29.

What interventions are being tested in trial NCT03696225?

The interventions under investigation include: Treatment as Usual (TAU) (BEHAVIORAL), Compensatory Cognitive Training (CCT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03696225?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.